Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

This study has been completed.

Sponsor:

Collaborator:

Wyeth is now a wholly owned subsidiary of Pfizer

Information provided by:

French National Agency for Research on AIDS and Viral Hepatitis

ClinicalTrials.gov Identifier:

NCT00148824

First received: September 7, 2005

Last updated: March 20, 2008

Last verified: March 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2006
Estimated Primary Completion Date:	No date given

No publications provided by French National Agency for Research on AIDS and Viral Hepatitis

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Rabian C, Tschöpe I, Lesprit P, Katlama C, Molina JM, Meynard JL, Delfraissy JF, Chêne G, Lévy Y; ANRS 114 Pneumovac Study Group. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. Clin Infect Dis. 2010 Apr 15;50(8):1174-83.

To Top